Some pharmacologic characteristics of the human vas deferens.
D000109:Acetylcholine / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000328:Adult; D002628:Chemoreceptor Cells / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology; D008875:Middle Aged; D009388:Neostigmine / Q000494:pharmacology; D018377:Neurotransmitter Agents / Q000494:pharmacology*; D009538:Nicotine / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D014649:Vas Deferens / Q000187:drug effects*
D000318:Adrenergic beta-Agonists; D018377:Neurotransmitter Agents; D012701:Serotonin; D009388:Neostigmine; D008464:Mecamylamine; D009538:Nicotine; D006632:Histamine; D007545:Isoproterenol; D000109:Acetylcholine; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine